{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T11:13:46Z","timestamp":1773400426917,"version":"3.50.1"},"reference-count":40,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2020,2,26]],"date-time":"2020-02-26T00:00:00Z","timestamp":1582675200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0229121","type":"journal-article","created":{"date-parts":[[2020,2,26]],"date-time":"2020-02-26T13:34:27Z","timestamp":1582724067000},"page":"e0229121","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":15,"title":["In vitro evaluations on canine monocyte-derived dendritic cells of a nanoparticles delivery system for vaccine antigen against Echinococcus granulosus"],"prefix":"10.1371","volume":"15","author":[{"given":"Nad\u00e8ge","family":"Milhau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eyad","family":"Almouazen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvie","family":"Bouteille","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Im\u00e8ne","family":"Hellel-Bourtal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samira","family":"Azzouz-Maache","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uruguaysito","family":"Benavides","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Fran\u00e7oise","family":"Petavy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4206-1886","authenticated-orcid":true,"given":"Thierry","family":"Marchal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2020,2,26]]},"reference":[{"issue":"2","key":"pone.0229121.ref001","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ijid.2008.03.037","article-title":"Echinococcosis: a review","volume":"13","author":"P Moro","year":"2009","journal-title":"Int J Infect Dis"},{"key":"pone.0229121.ref002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biologicals.2017.10.003","article-title":"Current status and future prospective of vaccine development against Echinococcuc granulosus","volume":"51","author":"MM Pourseif","year":"2018","journal-title":"Biologicals"},{"key":"pone.0229121.ref003","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/bs.apar.2016.09.002","article-title":"Echinococcosis: Control and Prevention","volume":"96","author":"PS Craig","year":"2017","journal-title":"Adv Parasitol"},{"issue":"9","key":"pone.0229121.ref004","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1365-3024.1996.tb01029.x","article-title":"Vaccination against hydatidosis using a defined recombinant antigen","volume":"18","author":"MW Lightowlers","year":"1996","journal-title":"Parasite Immunol"},{"issue":"20","key":"pone.0229121.ref005","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1016\/j.vaccine.2012.02.073","article-title":"Vaccination of bovines against Echinococcus granulosus (cystic echinococcosis)","volume":"30","author":"DD Heath","year":"2012","journal-title":"Vaccine"},{"issue":"5","key":"pone.0229121.ref006","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.apjtm.2017.05.011","article-title":"Genetic diversity and phylogenetic analysis of EG95 sequences of Echinococcus granulosus: Implications for EG95 vaccine application","volume":"10","author":"W Pan","year":"2017","journal-title":"Asian Pac J Trop Med"},{"issue":"7","key":"pone.0229121.ref007","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1086\/506622","article-title":"Vaccination of dogs against Echinococcus granulosus, the cause of cystic hydatid disease in humans","volume":"194","author":"W Zhang","year":"2006","journal-title":"J Infect Dis"},{"key":"pone.0229121.ref008","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s40249-018-0425-4","article-title":"Dog vaccination with EgM proteins against Echinococcus granulosus","volume":"7","author":"Z Zhang","year":"2018","journal-title":"Infect Dis Poverty"},{"issue":"2","key":"pone.0229121.ref009","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00436-005-1322-x","article-title":"Immunogenicity of two Echinococcus granulosus antigens EgA31 and EgTrp in mice","volume":"96","author":"M Fraize","year":"2005","journal-title":"Parasitol Res"},{"issue":"1","key":"pone.0229121.ref010","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1371\/journal.pntd.0000125","article-title":"An oral recombinant vaccine in dogs against Echinococcus granulosus, the causative agent of human hydatid disease: a pilot study","volume":"2","author":"A-F Petavy","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"issue":"10","key":"pone.0229121.ref011","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1080\/21645515.2015.1063756","article-title":"Novel nanoparticle vaccines for Listeriosis","volume":"11","author":"R Calderon-Gonzalez","year":"2015","journal-title":"Hum Vaccines Immunother"},{"issue":"2","key":"pone.0229121.ref012","doi-asserted-by":"crossref","first-page":"e31472","DOI":"10.1371\/journal.pone.0031472","article-title":"Antigen-displaying lipid-enveloped PLGA nanoparticles as delivery agents for a Plasmodium vivax malaria vaccine","volume":"7","author":"JJ Moon","year":"2012","journal-title":"PloS One"},{"issue":"14","key":"pone.0229121.ref013","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1016\/j.vaccine.2015.02.016","article-title":"A novel dengue virus serotype-2 nanovaccine induces robust humoral and cell-mediated immunity in mice","volume":"33","author":"T Hunsawong","year":"2015","journal-title":"Vaccine"},{"key":"pone.0229121.ref014","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.addr.2016.06.018","article-title":"Polylactic acid (PLA) controlled delivery carriers for biomedical applications","volume":"107","author":"B Tyler","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"key":"pone.0229121.ref015","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3389\/fcimb.2013.00013","article-title":"Vaccine delivery using nanoparticles","volume":"3","author":"AE Gregory","year":"2013","journal-title":"Front Cell Infect Microbiol"},{"issue":"8","key":"pone.0229121.ref016","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nri3488","article-title":"Applications of nanotechnology for immunology","volume":"13","author":"DM Smith","year":"2013","journal-title":"Nat Rev Immunol"},{"issue":"1 Pt A","key":"pone.0229121.ref017","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.imlet.2014.07.004","article-title":"Targeting human dendritic cells in situ to improve vaccines","volume":"162","author":"K Sehgal","year":"2014","journal-title":"Immunol Lett"},{"issue":"12","key":"pone.0229121.ref018","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.it.2006.10.005","article-title":"Targeting dendritic cells with biomaterials: developing the next generation of vaccines","volume":"27","author":"ST Reddy","year":"2006","journal-title":"Trends Immunol"},{"issue":"2","key":"pone.0229121.ref019","first-page":"926","article-title":"Monophosphoryl lipid A activates both human dendritic cells and T cells","volume":"168","author":"J Ismaili","year":"2002","journal-title":"J Immunol Baltim Md 1950"},{"issue":"6","key":"pone.0229121.ref020","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s00436-002-0791-4","article-title":"A tropomyosin gene is differentially expressed in the larval stage of Echinococcus granulosus","volume":"89","author":"A Esteves","year":"2003","journal-title":"Parasitol Res"},{"issue":"2","key":"pone.0229121.ref021","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/02652040400026442","article-title":"Poly(D,L-lactide-co-glycolide) protein-loaded nanoparticles prepared by the double emulsion method\u2014processing and formulation issues for enhanced entrapment efficiency","volume":"22","author":"U Bilati","year":"2005","journal-title":"J Microencapsul"},{"issue":"1\u20132","key":"pone.0229121.ref022","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.vetimm.2005.08.027","article-title":"CD86 molecule is a specific marker for canine monocyte-derived dendritic cells","volume":"109","author":"C Bonnefont-Rebeix","year":"2006","journal-title":"Vet Immunol Immunopathol"},{"issue":"3\u20134","key":"pone.0229121.ref023","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.vetimm.2012.12.003","article-title":"Species-specific properties and translational aspects of canine dendritic cells","volume":"151","author":"V Qeska","year":"2013","journal-title":"Vet Immunol Immunopathol"},{"issue":"4","key":"pone.0229121.ref024","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.nano.2010.01.001","article-title":"Nanotechnology-based manipulation of dendritic cells for enhanced immunotherapy strategies","volume":"6","author":"R Klippstein","year":"2010","journal-title":"Nanomedicine Nanotechnol Biol Med"},{"issue":"3","key":"pone.0229121.ref025","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.vaccine.2013.11.069","article-title":"Nanoparticle vaccines","volume":"32","author":"L Zhao","year":"2014","journal-title":"Vaccine"},{"key":"pone.0229121.ref026","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12929-015-0195-2","article-title":"Preparation, characterization and immunological evaluation: canine parvovirus synthetic peptide loaded PLGA nanoparticles","volume":"22","author":"S Derman","year":"2015","journal-title":"J Biomed Sci"},{"issue":"11","key":"pone.0229121.ref027","doi-asserted-by":"crossref","first-page":"e0165477","DOI":"10.1371\/journal.pone.0165477","article-title":"In Vitro Evaluation of the Biological Responses of Canine Macrophages Challenged with PLGA Nanoparticles Containing Monophosphoryl Lipid A","volume":"11","author":"D Guldner","year":"2016","journal-title":"PloS One"},{"issue":"2","key":"pone.0229121.ref028","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ijpharm.2005.03.035","article-title":"Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model","volume":"298","author":"C Foged","year":"2005","journal-title":"Int J Pharm"},{"issue":"1","key":"pone.0229121.ref029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ymeth.2006.05.016","article-title":"Pathogen recognition and development of particulate vaccines: does size matter?","volume":"40","author":"SD Xiang","year":"2006","journal-title":"Methods San Diego Calif"},{"issue":"Suppl 1","key":"pone.0229121.ref030","first-page":"51","article-title":"Endocytosis and exocytosis of nanoparticles in mammalian cells","volume":"9","author":"N Oh","year":"2014","journal-title":"Int J Nanomedicine"},{"issue":"17","key":"pone.0229121.ref031","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.2217\/nnm.14.135","article-title":"Development of functionalized nanoparticles for vaccine delivery to dendritic cells: a mechanistic approach","volume":"9","author":"JM Silva","year":"2014","journal-title":"Nanomed"},{"issue":"2","key":"pone.0229121.ref032","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.ijpharm.2013.05.025","article-title":"Toxicity of surface-modified PLGA nanoparticles toward lung alveolar epithelial cells","volume":"454","author":"N Grabowski","year":"2013","journal-title":"Int J Pharm"},{"issue":"3","key":"pone.0229121.ref033","first-page":"165","article-title":"Characterization of canine monocyte-derived dendritic cells with phenotypic and functional differentiation","volume":"71","author":"Y-S Wang","year":"2007","journal-title":"Can J Vet Res"},{"issue":"1","key":"pone.0229121.ref034","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.cellimm.2010.03.003","article-title":"Canine-DCs using different serum-free methods as an approach to provide an animal-model for immunotherapeutic strategies","volume":"263","author":"D Bund","year":"2010","journal-title":"Cell Immunol"},{"issue":"1\u20132","key":"pone.0229121.ref035","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jim.2005.02.001","article-title":"Functional canine dendritic cells can be generated in vitro from peripheral blood mononuclear cells and contain a cytoplasmic ultrastructural marker","volume":"298","author":"C Ibisch","year":"2005","journal-title":"J Immunol Methods"},{"issue":"5","key":"pone.0229121.ref036","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.4049\/jimmunol.178.5.2979","article-title":"Targeting of antigen to dendritic cells with poly (gamma-glutamic acid) nanoparticles induces antigen-specific humoral and cellular immunity","volume":"178","author":"T Uto","year":"2007","journal-title":"J Immunol"},{"key":"pone.0229121.ref037","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejpb.2016.05.018","article-title":"PLGA nanoparticles modified with a TNFalpha mimicking peptide, soluble Leishmania antigens and MPLA induce T cell priming in vitro via dendritic cell functional differentiation","volume":"105","author":"M Margaroni","year":"2016","journal-title":"Eur J Pharm Biopharm"},{"issue":"19","key":"pone.0229121.ref038","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1016\/j.vaccine.2003.12.032","article-title":"Characterization of poly (D,L-lactic-co-glycolic acid) based nanoparticulate system for enhanced delivery of antigens to dendritic cells","volume":"22","author":"P Elamanchili","year":"2004","journal-title":"Vaccine"},{"issue":"38","key":"pone.0229121.ref039","doi-asserted-by":"crossref","first-page":"10305","DOI":"10.1016\/j.biomaterials.2013.09.038","article-title":"The use of nanolipoprotein particles to enhance the immunostimulatory properties of innate immune agonists against lethal influenza challenge","volume":"34","author":"DR Weilhammer","year":"2013","journal-title":"Biomaterials"},{"issue":"16","key":"pone.0229121.ref040","doi-asserted-by":"crossref","first-page":"4052","DOI":"10.1016\/j.biomaterials.2011.02.011","article-title":"In vivo evidence of oral vaccination with PLGA nanoparticles containing the immunostimulant monophosphoryl lipid A","volume":"32","author":"F Sarti","year":"2011","journal-title":"Biomaterials"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0229121","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,26]],"date-time":"2020-02-26T13:34:53Z","timestamp":1582724093000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0229121"}},"subtitle":[],"editor":[{"given":"Alain","family":"Haziot","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,2,26]]},"references-count":40,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,2,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0229121","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,26]]}}}